Trial intelligence / Profile preview

Intracoronary injection of Integrilin in STEMI

IRCT20140512017666N3Phase 3Completed

Sponsor
Tabriz University of Medical Sciences
Start
Dec 2019
Modality
Peptides
Countries
1
01

Overview

Phase 3 trial of eptifibatide in myocardial infarction (MI), sponsored by Tabriz University of Medical Sciences. Started Dec 2019; status: completed.

02

Drugs

eptifibatide
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on IRCT20140512017666N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20140512017666N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call